Works by Weiss, Geoffrey R.


Results: 16
    1
    2
    3
    4
    5
    6

    An Outbreak of Hepatitis A among Cancer Patients Treated with Interleukin-2 and Lymphokine-Activated Killer Cells.

    Published in:
    Journal of Infectious Diseases, 1990, v. 161, n. 4, p. 647, doi. 10.1093/infdis/161.4.647
    By:
    • Weisfuse, Isaac B.;
    • Graham, David J.;
    • Will, Marcia;
    • Parkinson, David;
    • Snydman, David R.;
    • Atkins, Michael;
    • Karron, Ruth A.;
    • Feinstone, Stephen;
    • Rayner, Anthony A.;
    • Fisher, Richard I.;
    • Mills, Bonnie J.;
    • Dutcher, Janice R;
    • Weiss, Geoffrey R.;
    • Glover, Alice;
    • Kuritsky, Joel N.;
    • Hadler, Stephen C.
    Publication type:
    Article
    7

    Metastatic Renal Cancer Treated with Interleukin--2 and Lymphokine--Activated Killer Cells.

    Published in:
    Annals of Internal Medicine, 1988, v. 108, n. 4, p. 518, doi. 10.7326/0003-4819-108-4-518
    By:
    • Fisher, Richard I.;
    • Coltman Jr., Charles A.;
    • Doroshow, James H.;
    • Rayner, Anthony A.;
    • Hawkins, Michael J.;
    • Mier, James W.;
    • Wiernik, Peter;
    • McMannis, John D.;
    • Weiss, Geoffrey R.;
    • Margolin, Kim A.;
    • Gemlo, Brett T.;
    • Hoth, Daniel F.;
    • Parkinson, David R.;
    • Paietta, Elisabeth
    Publication type:
    Article
    8
    9
    10
    11
    12

    Phase I Clinical and Pharmacokinetic Trial of Flavone Acetic Acid.

    Published in:
    JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 2, p. 124
    By:
    • Havlin, A. Kathleen;
    • Kuhn, John G.;
    • Craig, John B.;
    • Boldt, David H.;
    • Weiss, Geoffrey R.;
    • Koeller, James;
    • Harman, Glenn;
    • Schwartz, Rowena;
    • Clark, Gary N.;
    • Von Hoff, Daniel D.
    Publication type:
    Article
    13

    Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 17, p. 1397
    By:
    • Gaynor, Ellen R.;
    • Weiss, Geoffrey R.;
    • Margolin, Kim A.;
    • Aronson, Frederick R.;
    • Sznol, Mario;
    • Demchak, Paul;
    • Grima, Kathleen M.;
    • Fisher, Richard I.;
    • Boldt, David H.;
    • Doroshow, James H.;
    • Bar, Michael H.;
    • Hawkins, Michael J.;
    • Mier, James W.;
    • Caliendo, Geralyn
    Publication type:
    Article
    14
    15

    Melanoma NOS1 expression promotes dysfunctional IFN signaling.

    Published in:
    2014
    By:
    • Liu, Qiuzhen;
    • Tomei, Sara;
    • Ascierto, Maria Libera;
    • De Giorgi, Valeria;
    • Bedognetti, Davide;
    • Dai, Cuilian;
    • Uccellini, Lorenzo;
    • Spivey, Tara;
    • Pos, Zoltan;
    • Thomas, Jaime;
    • Reinboth, Jennifer;
    • Murtas, Daniela;
    • Zhang, Qianbing;
    • Chouchane, Lotfi;
    • Weiss, Geoffrey R;
    • Slingluff Jr, Craig L;
    • Lee, Peter P;
    • Rosenberg, Steven A;
    • Alter, Harvey;
    • Yao, Kaitai
    Publication type:
    journal article
    16

    Melanoma NOS1 expression promotes dysfunctional IFN signaling.

    Published in:
    Journal of Clinical Investigation, 2014, v. 124, n. 5, p. 2147, doi. 10.1172/JCI69611
    By:
    • Qiuzhen Liu;
    • Tomei, Sara;
    • Ascierto, Maria Libera;
    • De Giorgi, Valeria;
    • Bedognetti, Davide;
    • Cuilian Dai;
    • Uccellini, Lorenzo;
    • Spivey, Tara;
    • Pos, Zoltan;
    • Thomas, Jaime;
    • Reinboth, Jennifer;
    • Murtas, Daniela;
    • Qianbing Zhang;
    • Chouchane, Lotfi;
    • Weiss, Geoffrey R.;
    • Slingluff Jr., Craig L.;
    • Lee, Peter P.;
    • Rosenberg, Steven A.;
    • Alter, Harvey;
    • Kaitai Yao
    Publication type:
    Article